ARCHIVES

Xeloda As Effective As 5-FU/LV, Five-Year Survival Data Show

This article is from The Cancer Letter archive.

Vol. 30 No. 9 | September 28, 2007

Download PDF Visit The Full Archive

Related Articles

Tamoxifen Makes ER-Negative Breast Cancer Easier To Find

October 31, 2008

NCI Bid For New Clinical Review Panel Rejects; But Invites Researchers To ‘Submit Best Ideas’

March 8, 1991

CCOP Recompetition Approved, “Institutionalized;” Board Okays Concept For Eight Minority CCOPs

February 3, 1989

In Brief: Friedman Named FDA Deputy Commissioner; Parkinson To Lead CTEP; Walsh Resigns

September 22, 1995

Phase III Trial Data: Lenvatinib Extends PFS by Over 14 Months

June 27, 2014

US, Italy Plan Greater Scientific Collaboration

May 16, 2003